Irritable Bowel Syndrome
Conditions
Interventions
Patients will be randomly allocated to 6 sessions of individual hypnotherapy, 6
sessions of group-hypnotherapy or 6 sessions of educational-supportive therapy
in a group (placebo).
Sponsors
Universitair Medisch Centrum Utrecht
Eligibility
Age
18 Years to 99 Years
Inclusion criteria
Inclusion criteria: Patients aged 18-65 years in primary and secondary care , who are diagnosed with IBS (Rome III criteria)
Exclusion criteria
Exclusion criteria: Patients unable to understand the content of the sessions, because of insufficient command of the Dutch language. Patients unable to fill in the questionnaires. Patients unable (for example: too aggressive) or unwilling to function in a group. Patients in whom a` psychiatric condition needs attention first (for example severe depression or psychosis). Patients who have IBS and other chronic bowel diseases, as far as they are already diagnosed, such as ulcerative colitis, Crohn*s disease or coeliac disease. Patients who have undergone major surgery to the lower gastrointestinal tract, such as partial or total colectomy, small bowel resection or partial or total gastrectomy.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The primary efficacy parameter is the responder rate for IBS symptoms based on a weekly assessment of Adequate Relief (AR) score. | — |
Secondary
| Measure | Time frame |
|---|---|
| Secondary efficacy parameters are changes in the IBS Symptom Severity Score (IBS-SSS) and Quality of Life (IBS-Qol), cognitions, self-efficacy, psychological complaints and direct and indirect costs of the disease, measured as the costs of visits to doctors and alternative healers, use of medicines and loss of labour productiveness. | — |
Countries
Netherlands
Outcome results
None listed